Lanzhou Foci Pharmaceutical Co Ltd (002644)

Currency in CNY
9.29
-0.09(-0.96%)
Delayed Data·
002644 Scorecard
Full Analysis
Trading at a high earnings multiple
002644 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.279.40
52 wk Range
6.1611.85
Key Statistics
Bid/Ask
9.28 / 9.29
Prev. Close
9.38
Open
9.36
Day's Range
9.27-9.4
52 wk Range
6.16-11.85
Volume
6.68M
Average Volume (3m)
17.12M
1-Year Change
42.6%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002644 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Lanzhou Foci Pharmaceutical Co Ltd Company Profile

LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the Min Shan and Foci brands. It also engages in planting and selling of Chinese medicinal materials; processing and selling of Chinese herbal medicine pieces; and production and sales of medical devices such as protective masks. In addition, the company exports its products. LanZhou Foci Pharmaceutical Co.,Ltd. was founded in 1929 and is based in Lanzhou, China. LanZhou Foci Pharmaceutical Co.,Ltd. is a subsidiary of Lanzhou Foci pharmaceutical industry development Group co., ltd.

Employees
1362
Market
China

Compare 002644 to Peers and Sector

Metrics to compare
002644
Peers
Sector
Relationship
P/E Ratio
88.6x31.7x−0.5x
PEG Ratio
4.72−0.430.00
Price/Book
2.6x3.1x2.6x
Price / LTM Sales
5.3x4.9x3.3x
Upside (Analyst Target)
-20.4%38.7%
Fair Value Upside
Unlock5.2%5.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.12%
Dividend Yield
0.13%
Industry Median 1.42%
Annualised payout
0.01
Paid annually
5-Years Growth
-27.52%
Growth Streak

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
0.04 / --
Revenue / Forecast
216.12M / --
EPS Revisions
Last 90 days

002644 Income Statement

FAQ

What Stock Exchange Does Lanzhou Foci Pharmaceutical A Trade On?

Lanzhou Foci Pharmaceutical A is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Lanzhou Foci Pharmaceutical A?

The stock symbol for Lanzhou Foci Pharmaceutical A is "002644."

What Is the Lanzhou Foci Pharmaceutical A Market Cap?

As of today, Lanzhou Foci Pharmaceutical A market cap is 4.75B.

What Is Lanzhou Foci Pharmaceutical A's Earnings Per Share (TTM)?

The Lanzhou Foci Pharmaceutical A EPS (TTM) is 0.12.

From a Technical Analysis Perspective, Is 002644 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Lanzhou Foci Pharmaceutical A Stock Split?

Lanzhou Foci Pharmaceutical A has split 3 times.

How Many Employees Does Lanzhou Foci Pharmaceutical A Have?

Lanzhou Foci Pharmaceutical A has 1362 employees.

What is the current trading status of Lanzhou Foci Pharmaceutical A (002644)?

As of 27 Aug 2025, Lanzhou Foci Pharmaceutical A (002644) is trading at a price of 9.29, with a previous close of 9.38. The stock has fluctuated within a day range of 9.27 to 9.40, while its 52-week range spans from 6.16 to 11.85.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.